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Abstract  
Inhibitory GABAergic neurons in the parafacial zone (PZGABA) are essential 
for slow wave sleep (SWS). Since existing literature about the heterogenous 
population of PZ neurons is lacking, questions remain regarding the non-
GABAergic sleep active PZ neurons. This study seeks to determine if 
glutamatergic PZ neurons expressing the transcription factor Phox2B (PZPhox2B) 
participate in sleep-wake control. Phox2B-IRES-Cre mice received injections of 
adeno-associated virus containing Cre-dependent diphtheria toxin subunit A (DTA) 
DNA into the PZ (PZPhox2B-DTA). Analysis of injection sites revealed transfection 
covering the PZ and the locus coeruleus, also known to express Phox2B. We 
recorded the sleep-wake cycle of PZPhox2B-DTA mice and compared them with 
control mice, analyzing their sleep-wake quantity, fragmentation, and power 
spectral distribution.  
We found total amounts and cortical power for wakefulness, SWS, and REM 
sleep of PZPhox2B-DTA mice were unaffected. There was fragmentation in 
wakefulness during the active period for PZPhox2B-DTA mice, seen as a significant 
reduction in the amount of time and number of episodes spent in the longest bout; 
however, wakefulness during the rest period was not significantly altered. No 
significant change was found in the bout numbers and amounts for SWS and REM 
sleep of PZPhox2B-DTA mice. I was unable to confirm targeted ablation of PZPhox2B-
DTA neurons due to a lack of reliable antibody staining. Therefore, it remains 
possible that ablation of PZPhox2B neurons was incomplete and the wakeful 
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fragmentation is due to neuronal ablation outside of the PZ, such as in the 
neighboring LC.   
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Chapter 1  
 
Introduction 
 
Understanding sleep 
A vital part of life 
Sleep is one of the more highly evolutionarily conserved behaviors among 
living organisms. Every animal species studied to date, from jellyfish to humans, 
has exhibited a sleep-like state despite the vulnerability of doing so (Lesku & Ly, 
2017; Lima et al., 2005). Humans spend about one-third of their lives asleep, 
totaling about 28 years. No other single activity has so much time dedicated to it, 
suggesting sleep plays a vital role throughout human life. As such, sleep is an 
important field of scientific inquiry.  
Sleep appears as a period of inactivity due to relative unresponsiveness to 
external stimuli, but is a highly organized, complex, and dynamic state that is 
naturally occurring, periodic, and reversible (Neckelmann & Ursin, 1993). The 
cooperative interplay of many neuronal networks generates and regulates the 
sleep-wake cycle (Gompf & Anaclet, 2020). The brain’s overall electrical activity 
changes significantly between wakefulness and sleep, cycling through several 
discrete states with corresponding alterations to the neural, endocrine, and 
somatic systems (Aldabal & Bahammam, 2011; Fink et al., 2018). A massive 
reorganization of gene expression takes place upon transitioning from wake to 
sleep, altering molecular and cellular biology of the brain (Cirelli, 2005; Cirelli et 
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al., 2004). Additionally, an organism’s overall physiology undergoes significant 
changes in heart rate, body temperature, and muscle activity (Siegel, 2005).  
Sleep in health and disease 
While the exact physiological purpose remains a mystery, there are many 
functions known to be affected by the lack of sleep (Imeri & Opp, 2009; Lesku et 
al., 2011). The importance of this highly regulated process is evidenced by the 
presence of a sleep rebound mechanism designed to help ensure an organism 
recovers from too little sleep (Tobler & Borbély, 1985). Sleep’s essential role has 
been most dramatically demonstrated through rats when after three to four weeks 
of being deprived of all sleep, the rats died due to the breakdown of metabolic 
processes (Everson et al., 1989).  
Similar to nutrition and exercise, sleep is crucial for health and well-being, 
having far-reaching effects on many different physiological and cognitive functions. 
This includes the regulation of respiration rates, the regulation of hormone levels, 
thought processes, and emotional states (Arnal et al., 2015; Baglioni et al., 2010). 
Healthy sleep requires sufficient duration, good quality, appropriate timing, 
appropriate regularity, and the absence of sleep disturbances and disorders (Arnal 
et al., 2015; Blunden & Galland, 2014).  
Disrupted sleep correlates with many negative health consequences and is 
comorbid with a variety of diseases. Adults who experience sleep disruption but 
are otherwise healthy, report increased likelihood of accidents and poor balance 
(Tobler & Borbély, 1985; Van Dongen et al., 2003), increased emotional distress 
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and mood changes (Babson et al., 2010), trouble thinking and concentration 
(Killgore, 2010), and increased proinflammatory responses and weakened 
immunity (Imeri & Opp, 2009). Notably, sleep disruption has detrimental effects on 
learning and memory (Wagner et al., 2001) 
Longer-term consequences of sleep disruption include cardiovascular 
disease, hypertension, weight gain, diabetes, depression, and increased 
incidences of mortality (Cappuccio et al., 2011; Cappuccio et al., 2010). 
Additionally, sleep disruption can be a symptom of diseases such as Parkinson’s 
disease and epilepsy (Loddo et al., 2017; Méndez & Radtke, 2001).  
Poor sleep does not affect just the one individual. The impairment of poor 
sleep can bring harm to others, as seen with the increased prevalence of 
automobile crashes and surgery errors in sleep deprived individuals (Eastridge et 
al., 2003; Landrigan, 2008). Sleep has become an ever-increasing health issue for 
modern society (Rajaratnam & Arendt, 2001; Roth et al., 2011). In an effort to 
identify sleep problems, official publications are categorizing them based on the 
behavioral and physiological phenotypes patients display (American Academy of 
Sleep, 2014; American Psychiatric Association, 2013). Insomnias, disorders 
involving the inability to fall asleep or stay asleep, are an increasingly reported 
struggle and could lead to increased risk of other diseases (Fernandez-Mendoza 
& Vgontzas, 2013; Roth et al., 2011). Hypersomnias, disorders of excessive 
sleepiness, include conditions where an individual experiences sleep onset 
inappropriately such as narcolepsy (Burgess & Scammell, 2012). Sleep health 
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impacts the daily lives of millions of people, making sleep research a vast and 
important field of investigation.  
Sleep Research 
Experimental measures of sleep 
These shifts in an organism’s physiology, accompanied by changes in 
alertness and consciousness, are called vigilance states, as detailed later. It is 
important that differences between wakefulness and sleep be definable, 
identifiable, and measurable to study the vigilance states of the sleep-wake cycle. 
While various technologies facilitate researching sleep and wakefulness in 
humans, model organisms such as rodents facilitate studying vigilance states 
because it is so highly evolutionarily conserved (Dringenberg, 2019; Lesku et al., 
2019). Model organisms allow for additional dimensions in conducting research, 
such as genetic manipulation, organism alteration, variable isolation, and direct 
measurements of internal processes. Measurement and identification of vigilance 
states often utilizes electroencephalogram (EEG) recording of the brain, 
electromyogram (EMG) recording of muscles, electrooculogram (EOG) recording 
of eye movement, video recording, or changes in physiology such as breathing 
rate or body temperature.  
Electrodes placed on the head detect the brain’s electrical activity 
generated by neuronal firing. EEG is the difference of electrical potential measured 
between two electrodes, and is represented as a continuous waveform with 
variable amplitude and frequency (Timofeev et al., 2012). Amplitude, a measure 
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of electrical energy, is the distance from equilibrium to the wave peak or trough. 
(Dang-Vu et al., 2008). Frequency, measured in Hertz (Hz), is how many neuronal 
firing cycles occur in one second. High frequency reflects desynchronized activity 
of the neuronal assembly while low frequency indicates cortical synchronization 
(Moruzzi & Magoun, 1949). The waveform’s amplitude and frequency patterns are 
typical to each vigilance state, as detailed later.  
To reflect the different vigilance states of brain activity, EEG waveforms get 
classified into five frequency bands (Abo-Zahhad et al., 2015). The delta band 
ranges from 0 to 4 Hz. The theta band ranges from 4 to 9 Hz. The alpha band 
ranges from 9 to 15 Hz and the beta band ranges from 15 to 30 Hz. The remaining 
frequencies above 30 Hz are the gamma band. EEG machines recording the 
electrical activity of the brain provide a direct measurement of vigilance states 
(Hernan et al., 2017; Moruzzi & Magoun, 1949). 
Muscle activity and muscle tone recorded by EMG fluctuate from high 
activity to no activity across different vigilance states. The EOG records eye 
movement, which changes between vigilance states. Video cameras record 
physical behavior and body posture which can be used in complementation with 
other measures to facilitate identification and classification of vigilance state. 
Measuring multiple parameters increases confidence in classifying vigilance state. 
Many mouse-based experiments utilize EEG, EMG, and video methods, although 
it depends on what is being manipulated and what resources are available.  
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Vigilance states in humans 
Humans are diurnal so their wakeful activity occurs primarily during the 
daytime with resting at night. Wakefulness is one vigilance state and is 
characterized by conscious and responsive behavior, high motility, and high 
frequency activity on the cortical EEG reflecting the cortical desynchronization of 
conscious cognition (Hernan et al., 2017; Moruzzi & Magoun, 1949).  In 
wakefulness, there is high muscle activity and high muscle tone on the EMG.  
Since it progresses through a cycle of identifiable changes, sleep gets 
divided into the two vigilance states non-rapid eye movement (NREM) and rapid 
eye movement (REM). NREM sleep precedes REM sleep but does not require it, 
while REM sleep requires NREM sleep and is followed by wakefulness. NREM 
sleep in humans gets further subdivided into three stages based on distinct 
physiological changes and progressive alterations in recordable brain activity.  
At the first stage of NREM sleep, the transition between waking and 
sleeping, awaking a person is still easy (Neckelmann & Ursin, 1993). The EEG 
power distribution shifts from the high-frequency EEG activity associated with 
wakefulness to lower frequency alpha and theta waves.  
In the second stage of human NREM sleep, a person is much less 
responsive to external stimuli (Neckelmann & Ursin, 1993). While brain waves 
begin slowing, there are sudden higher frequency waves known as sleep spindles, 
and higher-amplitude slow waves called K-complexes (Forget et al., 2011). Sleep 
spindles occur at 7 to 15 Hz for 1 to 2 seconds and subjects woken right after a 
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sleep spindle occurrence report they were dreaming (Siclari et al., 2018). A K-
complex occurs in response to environmental stimuli, producing a high-amplitude 
biphasic wave composed of an initial sharply negative upward wave followed by a 
slower positive downward wave on the EEG (Forget et al., 2011). Gradual 
inactivation of wake-promoting neural networks leads to slower, more 
synchronized oscillation of neuronal and synaptic activity as the thalamus and 
cerebral cortex neurons generate lower frequency slow-wave patterns (David et 
al., 2013; Funk et al., 2017).  On the EMG, muscle tone decreases while respiration 
slows, and body temperature begins to decrease (Darwent et al., 2010; Okada et 
al., 1991).  
Deep sleep of stage three, also called slow wave sleep (SWS), is 
characterized by increasing amounts of delta waves, reflecting increased 
synchronization of cortical and thalamic activity (Dijk, 1995; Timofeev et al., 2012). 
High amplitude, low frequency activity primarily below 4 Hertz (Hz) is known as 
slow wave activity (SWA) and is used as an indicator of deep sleep (Abo-Zahhad 
et al., 2015).  Decreased responsiveness to outside stimuli, due to a reduction in 
neural arousal processes, makes it harder to wake a person (Neckelmann & Ursin, 
1993). On the EMG there is very little to no muscle activity, although low muscle 
tone is present (Okada et al., 1991). Respiration is slow and regular while the heart 
rate decreases, and the body temperature continues to diminish (Ma et al., 2018).  
In order to transition into REM sleep, NREM sleep must sequentially pass 
through all three stages and then back to stage two sleep (Carskadon & Dement, 
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2005). REM sleep’s cortical EEG contains an abundance of theta activity produced 
by the neurons in the hippocampus, the brain region beneath the cortex primarily 
responsible for memories. These hippocampal theta waves are seen during motor 
activity and during REM sleep, which makes them stand out since REM sleep is 
uniquely marked by the loss of muscle tone, a state known as muscle atonia, with 
intermittent muscle twitches and rapid movement of the eyes (Abo-Zahhad et al., 
2015; Chen et al., 2017; Peever & Fuller, 2017: Valencia Garcia et al., 2018). 
Intermittent muscle twitches may activate brain regions not activated by waking 
motor activity and may function to aid sensorimotor system development (Peever 
& Fuller, 2017; Sokoloff et al., 2015). Fluttering eye movements, as recordable by 
an EOG, are a way to immediately distinguish between NREM sleep and REM 
sleep since NREM sleep does not have eye movement. Heart rate speeds up but 
body temperature falls even further as temperature regulation decreases (Darwent 
et al., 2010). REM sleep then transitions to wakefulness before the sleep-wake 
cycle can start over (Carskadon & Dement, 2005).  
Overall, these changes, progressing from wakefulness to NREM sleep to 
REM sleep, comprise the sleep-wake cycle (Steriade et al., 2001). The first half of 
a person’s sleep cycle consists mostly of NREM sleep. This time spent in deep 
sleep appears to be the restful and restorative portion of sleep. Humans then 
progress to increasingly longer REM sleep bouts in the latter half of the night where 
the average NREM-REM sleep cycle duration is about 90 minutes with four to six 
REM cycles a night (Carskadon & Dement, 2005). Across development, the ratio 
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of REM sleep to NREM sleep decreases, then with aging the ratio of deep sleep 
to light sleep decreases even though total time spent sleeping remains the same 
through adulthood (Scullin & Bliwise, 2015).  
Vigilance states in mice 
Research utilizes rats and mice for investigations more targeted than 
human experimental designs can accommodate. In rodents, EEG electrodes get 
placed in the skull, above the cortex, thus providing improved recording as the skull 
is no longer a barrier filtering out higher frequencies. A mouse’s thinner cortex 
allows recording of the theta rhythms from the hippocampus. Mice also offer both 
genetic manipulation and higher throughput, which are not possible with humans.  
Although mice have three sleep states like humans, there are some 
important differences. NREM in rats and mice is not as easily distinguished into 
sub-stages. Since the slow waves in NREM on the EEG are most distinguishable, 
this state is sometimes called slow wave sleep (SWS). Mice are nocturnal and in 
lab housing, do not sleep in one large continuous length of time. Instead, lab-
housed mice sleep in several bouts across the day, interspersed with wakeful 
activity.  
EEG recordings are the primary method used to determine a mouse’s 
vigilance state and measure the amount and quality of sleep. The EMG serves to 
further confirm vigilance states such as REM sleep. If needed, video recordings 
can provide visual determination to supplement the analysis.  
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In mice, the wakeful state, characterized by engaging with the environment, 
occurs primarily during the night. Cortical EEG recordings are rich in low amplitude, 
high-frequency beta and gamma waves, characteristics of perception and 
cognition. The EMG shows high muscle activity, reflective of the locomotor activity 
level. Conversely, high amplitude, low-frequency delta waves in the EEG 
characterizes SWS. The EMG records low muscle tone as the mouse relaxes into 
the stereotypical posture for sleeping. Lastly, hippocampal theta rhythms dominate 
the EEG during REM sleep in mice. During REM sleep, the EMG recording goes 
flat, indicative of muscle atonia. An awakening always follows REM sleep, which 
may last only one to two seconds.  
Sleep-wake circuitry 
Anatomy and neurochemistry  
The anatomy and neurochemistry of sleep-wake control is diverse and 
widely distributed throughout the brain (Figure 1.1 - 1.3 on pages 27 - 29). Recent 
technological advancements allow for better specific selection of targeted neurons 
and more diverse ways of manipulating the neuronal activity to interrogate their 
function and to determine their neural circuitry (Drew et al., 2018; Fuller et al., 
2015; Shiromani & Peever, 2017). This has facilitated revealing the control of sleep 
and wakefulness are established by a complex array of interconnected activation 
and inhibition.  
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Wakefulness  
The first identified wake-promoting brain region, the reticular activating 
system, was discovered by stimulating the brain between the pons and the 
midbrain. This reticular activating system projects to the cortex mainly through a 
ventral ascending pathway via the basal forebrain (BF), posterior and lateral 
hypothalamus (LH) and the medial forebrain bundle, and a dorsal ascending 
pathway through the thalamus (Jones & Yang, 1985). Subsequent investigation 
shows the wake-promoting brain regions are populated by a variety of neural 
subtypes that often contribute to cognition beyond sleep-wake control. For 
example, cholinergic innervation of the cortex and hippocampus are critical parts 
of cognitive processes such as selective attention and emotional processing 
(Bentley et al., 2003; Butcher et al., 1993; Dautan et al., 2016; Li et al., 2018). 
Dopaminergic neural activity plays a large role in learning and many motivation-
based behaviors such as eating and drug seeking (Corbit & Janak, 2010; Ostlund 
et al., 2011; Salamone, 1994; Salamone & Correa, 2009; Smith et al., 2011; 
Steinberg et al., 2013). Noradrenergic neurons activate in response to novelty and 
stress (Pudovkina et al., 2001; Ronzoni et al., 2016), contributing to cognitive 
processes such as shifts in attention, memory consolidation and retrieval, and 
decision making (Borodovitsyna et al., 2017; Sara, 2009). Orexinergic neurons are 
involved in arousal and response to homeostatic challenges such as food seeking 
(Sakurai et al., 1998; Yamanaka et al., 2003).  Investigation has also identified 
additional neuronal populations that contribute to wakefulness.  
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One of the most prominent wake-promoting brain regions is the basal 
forebrain (BF). Cholinergic neurons in the BF project to the hippocampus, 
hypothalamus, amygdala, and cerebral cortex (Henny & Jones, 2008; Mesulam et 
al., 1983). Chemogenetic activation and selective inhibition of cholinergic BF 
neurons revealed they contribute to wakefulness by inhibiting cortical 
synchronization (Anaclet et al., 2015; Chen et al., 2016).  GABAergic neurons in 
the BF project to the hypothalamus, amygdala, and cerebral cortex (Gritti et al., 
1993, 1994; Gritti et al., 1997; McDonald et al., 2011). Chemogenetic activation 
and selective inhibition of GABAergic BF neurons demonstrated they play an 
essential role in wake-promotion and desynchronization of the cortex (Anaclet et 
al., 2015; Kim et al., 2015).  
The glutamatergic neurons in the parabrachial nucleus (PB) reciprocally 
provide excitatory projections with the cerebral cortex to promote wakefulness, and 
extensively innervate the BF, lateral hypothalamus (LH), and central nucleus of the 
amygdala (Kaur et al., 2017; Saper, 1982; Saper & Loewy, 1980). Furthermore, 
both activating and inhibiting, or bidirectional, optogenetic and chemogenetic 
manipulation of glutamatergic lateral PB neurons expressing the calcitonin gene-
related peptide demonstrated their essential role in promoting wakefulness during 
sleep in response to elevated CO2 levels (Kaur et al., 2017).  
Several portions of the hypothalamus are involved in sleep-wake control. 
The orexinergic neurons in the lateral hypothalamus (LH) have widespread 
projections throughout the brain, including to the LC, tuberomammillary nucleus 
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(TMN), BF, ventral tegmental area (VTA), midline thalamus, and cortex (Jones & 
Yang, 1985; Peyron et al., 1998; Yu et al., 2019). Intracerebroventricular injection, 
and optogenetic and chemogenetic activation of orexinergic LH neurons 
demonstrated their role in consolidating wakefulness into long bouts in opposition 
to accumulating sleep pressure (Adamantidis et al., 2007; de Lecea et al., 1998). 
Furthermore, orexinergic signaling was found to establish transition boundaries 
between sleeping and waking, the loss of which caused narcolepsy (Carter et al., 
2009; Lin et al., 1999). Histaminergic neurons in the TMN of the posterior 
hypothalamus project to a widespread and diffuse array of various sleep and wake 
regulating brain regions such as the neocortex, hippocampal formation, amygdala, 
basal ganglia, thalamus, superior colliculus, and cerebellum (Köhler et al., 1985). 
Histaminergic TMN innervation of the forebrain was shown to promote 
wakefulness and arousal (Garbarg et al., 1974; Liu et al., 2010). Histaminergic 
release on the ventrolateral preoptic area (VLPO) suppresses the sleep promotion 
action of the VLPO to increase wakefulness (Liu et al., 2010; Sherin et al., 1998). 
The GABAergic neurons in the ventral LH project to the TMN, ventrolateral 
periaqueductal gray, and LC (Venner et al., 2016). Chemogenetic activation of the 
GABAergic ventral LH neurons demonstrated their important role in promoting 
wakefulness (Venner et al., 2016). There are glutamatergic neurons in the 
supramammillary region of the caudal hypothalamus which also express nitric 
oxide synthase (NOS) (Pedersen et al., 2017). Bidirectional, chemogenetic 
manipulation of glutamatergic supramammillary neurons demonstrated their 
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significant role in promoting wakefulness (Pedersen et al., 2017). Furthermore, 
manipulations including NOS-expressing supramammillary neurons were found to 
not only drive wakefulness but also contribute to REM theta rhythms on EEG 
(Pedersen et al., 2017). The GABAergic neurons in the bed nucleus of the stria 
terminalis (BNST) project to the VTA (Kodani et al., 2017; Kudo et al., 2014). 
Optogenetic and chemogenetic stimulation of GABAergic BNST neurons 
demonstrated their contribution to transitioning from NREM sleep to wakefulness 
and to longer bouts of waking facilitated through orexinergic signaling (Kodani et 
al., 2017; Kudo et al., 2014).  
Noradrenergic neurons in the LC innervates and receives descending 
projections from the anterior cingulate cortex to promote wakefulness (Gompf et 
al., 2010; Jones & Yang, 1985; Luppi et al., 1995; Schwarz et al., 2015). 
Optogenetic interrogation and CRISPR/cas9 genetic editing of noradrenergic LC 
neurons demonstrated their role in promoting wakefulness and orexinergic 
mediated transitioning from sleep to wake (Carter et al., 2012; Yamaguchi et al., 
2018). Furthermore, noradrenergic LC neurons project to and activate neural 
circuitry known as REM-off neurons to inhibit REM sleep (Lu et al., 2006).  
The dopaminergic neurons in the VTA project to the striatum, medial 
prefrontal cortex, nucleus accumbens (NAc), and central amygdala (Eban-
Rothschild et al., 2016; Qiu et al., 2019). Bidirectional chemogenetic and 
optogenetic manipulations of the dopaminergic VTA innervations on the ventral 
striatum demonstrated dopaminergic VTA neurons promote wakefulness during 
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salient activities and facilitates transition from REM sleep to wakefulness (Eban-
Rothschild et al., 2016; Qiu et al., 2019; Yang et al., 2018). Additionally, 
dopaminergic neurons in the dorsal raphe nucleus support wakefulness during 
environmental salience (Cho et al., 2017). The glutamatergic neurons in the VTA 
project to the NAc and the LH (Taylor et al., 2014; Yu et al., 2019). Lesion and 
chemogenetic activation of glutamatergic VTA neurons demonstrated how they 
consolidate wakefulness through stimulation of the NAc and the LH (Yu et al., 
2019). GABAergic neurons in the NAc of the ventral striatum project back to the 
VTA (Luo et al., 2018). Optogenetic and chemogenetic stimulation of GABAergic 
NAc neurons demonstrated their contribution to induction and maintenance of 
wakefulness (Luo et al., 2018). Additionally, GABAergic neurons in the superior 
colliculus project to the VTA to facilitate induction of wakefulness during transition 
to darkness (Ze Zhang et al., 2019).  
Glutamatergic neurons in the pedunculopontine tegmental nuclei (PPT) 
project to the caudal basal forebrain, ventral part of the BNST, subthalamic 
nucleus, substantia nigra (SNc), and VTA (Kroeger et al., 2017). Bidirectional 
chemogenetic manipulation of glutamatergic PPT neurons demonstrated their 
contribution to promoting quiet wakefulness (Kroeger et al., 2017). Cholinergic 
neurons in the PPT project to the reticular nucleus of the thalamus, anterior 
pretectal nucleus and superior colliculus (Kroeger et al., 2017). Chemogenetic 
activation of cholinergic PPT neurons demonstrated their role in reducing NREM 
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sleep by reducing cortical slow waves during NREM sleep and increasing 
transitions to wakefulness (Kroeger et al., 2017).   
While the reticular formation’s ascending ventral pathway projects directly 
to the forebrain, the cortex reciprocally innervates the wake promoting systems, 
such as the LC and PB, demonstrating the possibility of exerting executive control 
over sleep-wake regulation (Breton-Provencher & Sur, 2019; Saper, 1982). The 
reticular formation’s ascending dorsal pathway projects to the thalamus which then 
relays the arousal signals through thalamocortical neurons. Glutamatergic neurons 
in the paraventricular thalamus (PVT) project to the NAc and receive projection 
from the LH (Ren et al., 2018). This network has been shown to be essential for 
sustained, time-of-day dependent wakefulness (Ren et al., 2018). Matrix cells in 
the ventromedial thalamic nucleus (VM) project to almost the entire cortex (Honjoh 
et al., 2018). Optogenetic stimulation and chemogenetic inhibition of matrix cells 
in the VM demonstrated they contribute to transitioning from NREM sleep to 
wakefulness (Honjoh et al., 2018). Additionally, both glutamatergic PVT and VM 
matrix cells have been shown to contribute to emergence from isoflurane induced 
unconsciousness (Honjoh et al., 2018; Ren et al., 2018). Glutamatergic neurons in 
the dorsomedial thalamus (DMT) project throughout the forebrain, including to 
prelimbic cortices, the NAc, and the central amygdala (Mátyás et al., 2018). 
Glutamatergic DMT neuronal activity transitions the cortical state from NREM 
sleep to arousal with a drop in delta power, achieved by the unique characteristic 
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of each neuron having multiple axon arbors branching out to multiple brain areas 
so one neuron can affect a wide region across the brain (Mátyás et al., 2018).  
NREM sleep 
The NREM sleep system is also distributed throughout the brain and much 
like with wakefulness, some of the sleep-promoting neuronal populations are part 
of the hypothalamus. The ventrolateral preoptic area (VLPO) of the anterior 
hypothalamus was the first NREM sleep-promoting region found. GABAergic and 
galaninergic neurons in the VLPO project to wake-promoting regions such as the 
tuberomammillary nucleus (TMN), locus coeruleus (LC), and raphe nuclei (Sherin 
et al., 1998). Optogenetic and chemogenetic activation of the inhibitory GABAergic 
and galaninergic VLPO neurons demonstrate their role in facilitating transition to 
NREM sleep by inhibiting wakefulness and maintaining NREM sleep (Kroeger et 
al., 2018). GABAergic and galaninergic neurons in the dorsomedial hypothalamus 
(DMH) project to the preoptic area (Chen et al., 2018). Bilateral optogenetic 
manipulation of galaninergic DMH neurons demonstrated their role in suppressing 
REM sleep (Chen et al., 2018).  
Adenosine is a sleep factor produced by neuronal metabolism, increasing 
in accumulation during prolonged wakefulness, and believed to play a role in sleep 
pressure (Basheer et al., 2000; Basheer et al., 2004; Porkka-Heiskanen et al., 
1997). Of the four adenosine receptor (AR) types, A1 AR and A3 AR inhibit neuronal 
signaling while A2A AR and A2B AR are excitatory (Borea et al., 2016; Sheth et al., 
2014).  
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Microdialysis and cellular recordings demonstrated the role of A1 AR in 
inhibiting wake-promoting brain areas such as the BF cholinergic neurons, LH 
orexinergic neurons, and TMN histaminergic neurons (Alam et al., 1999; Liu & 
Gao, 2007; Oishi et al., 2008; Rainnie et al., 1994; Thakkar et al., 2003). Also, A1 
AR disinhibits sleep-active neurons such as the VLPO and the anterior 
hypothalamic area (Chamberlin et al., 2003; Gallopin et al., 2005; Morairty et al., 
2004). Use of agonists and antagonists demonstrated A1 AR’s role in increasing 
NREM consolidation and SWA response following acute sleep deprivation 
(Benington et al., 1995; Gass et al., 2009; Methippara et al., 2005; Radulovacki et 
al., 1984; Thakkar et al., 2008; Virus et al., 1990). Like with adenosine levels, A1 
AR expression increases with prolonged wakefulness and resolves during sleep 
(Basheer et al., 2007; Elmenhorst et al., 2017; Elmenhorst et al., 2007).  
A2 AR is expressed in the VLPO and NAc. Sleep promoting neuronal sub-
population within the VLPO express A2A receptors and are activated by adenosine 
(Kumar et al., 2013). Use of agonists demonstrated A2 AR’s role in initiating sleep 
through activation of the VLPO and the NAc (Gallopin et al., 2005; Satoh et al., 
1999; Scammell et al., 2001). NAc neurons with A2A receptors project to the ventral 
pallidum (Oishi et al., 2017; Reppert et al., 1991). Optogenetic activation and 
bidirectional chemogenetic manipulation of these neurons revealed their 
contribution to sleep induction and how motivational stimuli suppresses their 
signaling (Oishi et al., 2017). Caffeine’s wakefulness effect is mediated through 
antagonism of A2 AR expressed in the NAc (Huang et al., 2005; Lazarus et al., 
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2011). A2 AR expressing neurons in the rostral striatum project to the globus 
pallidus to form inhibitory synapses with inhibitory globus pallidus parvalbumin 
interneurons (Yuan et al., 2017). Bidirectional chemogenetic manipulation of these 
striatal neurons demonstrated their contribution to promoting NREM sleep (Yuan 
et al., 2017).  
GABAergic neurons in the ventral zona incerta (VZI) have widespread 
connectivity throughout the brain and project to such neuronal populations as the 
orexinergic LH (Liu et al., 2017; Mitrofanis, 2005).  Bidirectional optogenetic and 
chemogenetic manipulations and conditional deletion of GABAergic VZI neurons 
demonstrated their essential role in NREM sleep control through orexinergic 
neurons (Liu et al., 2017).   
GABAergic neurons in the parafacial zone (PZ) project to the PB (Anaclet 
et al., 2014; Anaclet & Fuller, 2017). Lesion, optogenetic and chemogenetic 
activation, and knockdown of neurotransmission of GABAergic PZ neurons 
demonstrated their critical role in promoting NREM sleep by induction and 
maintenance of NREM sleep as well as stimulating SWA (Anaclet et al., 2014; 
Anaclet, Griffith, et al., 2018; Anaclet et al., 2012).  
GABAergic neurons in the rostromedial tegmental nucleus (RMTg) project 
to the midbrain dopaminergic system containing the VTA and the SNc (Yang et al., 
2018). Lesion, and optogenetic and chemogenetic stimulation of GABAergic RMTg 
neurons demonstrated their essential role in inducing NREM sleep and SWA 
(Yang et al., 2018).  
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Glutamatergic neurons in the perioculomotor region of the midbrain project 
to the sleep-promoting preoptic hypothalamus and posterior ventromedial medulla 
(Zhe Zhang et al., 2019). Ablation and bidirectional optogenetic and chemogenetic 
manipulation of the glutamatergic perioculomotor neurons demonstrated their 
contribution to induction and maintenance of NREM and to sleep recovery 
following deprivation (Zhe Zhang et al., 2019).  
Dopaminergic neurons in the SNc project to the dorsal striatum (Qiu et al., 
2019). Selective chemogenetic activation of the dopaminergic SNc innervation to 
the dorsal striatum demonstrated their contribution to promoting sleep (Qiu et al., 
2019). GABAergic neurons in the VTA project to the LH and innervate locally within 
the VTA (Chowdhury et al., 2019; Taylor et al., 2014; Yu et al., 2019). Lesion, 
bidirectional optogenetic and chemogenetic manipulation, and cellular recording 
of GABAergic VTA neurons demonstrated their essential role in inducing and 
maintaining NREM sleep by inhibiting the wake-promoting activity from the LH and 
VTA (Chowdhury et al., 2019; Takata et al., 2018; Yu et al., 2019).  
GABAergic neurons of the ventrolateral periaqueductal gray (vlPAG) project 
to the REM-promoting sublaterodorsal nucleus (SLD) neurons, establishing 
reciprocal connection for mutual inhibition (Boissard et al., 2003; Kroeger et al., 
2019; Lu et al., 2006; Sapin et al., 2009). Optogenetic activation of the GABAergic 
vlPAG neurons demonstrated their essential role in stabilizing NREM sleep by 
suppressing REM sleep (Hsieh et al., 2011; Sakai, 2018; Weber et al., 2018).  
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Glutamatergic neurons in the deep mesencephalic nuclei (DpMe) project to 
the SLD (Liang et al., 2014). Chemogenetic activation of glutamatergic DpMe 
neurons demonstrated their prominent role in promoting NREM sleep by 
suppressing transition to REM sleep (Hayashi et al., 2015; Sakai, 2018). 
GABAergic neurons of the DpMe project to REM-promoting SLD neurons, 
establishing reciprocal connection for mutual inhibition (Liang et al., 2014; Lu et 
al., 2006). Lesion, optogenetic and pharmacological inactivation of GABAergic 
DpMe neurons demonstrated their role in suppressing transition into REM sleep 
(Hayashi et al., 2015; Lu et al., 2006; Sakai, 2018).  
Much like with wakefulness, the cortex participates in sleep promotion. Slow 
wave activity seems to be propagated by inhibitory cortical interneurons (Funk et 
al., 2017; Neske & Connors, 2016). Somatostatin GABAergic interneurons provide 
critical regulation to decreased neuronal excitability in the cortex to achieve slow 
wave firing patterns while parvalbumin GABAergic interneuron activity increases 
NREM sleep duration (Funk et al., 2017; Neske & Connors, 2016). Somatostatin 
GABAergic interneuron activity is also essential for SWA (Funk et al., 2017; Neske 
& Connors, 2016). Cortical neurons expressing neuronal NOS are activated by 
sleep and provide critical signaling for increasing SWA in response to sleep 
deprivation (Dittrich et al., 2015; Morairty et al., 2013). Pyramidal neurons from the 
prefrontal cortex innervate the LC, contributing to the inhibition exerted by 
GABAergic interneurons upon the LC (Breton-Provencher & Sur, 2019). 
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Interestingly, the cerebral cortex can produce slow oscillations without the 
thalamus (Timofeev & Steriade, 1996).  
However, optogenetic activation and microdialysis injections demonstrated 
the thalamus’ role in finely tuning slow waves in NREM sleep (David et al., 2013). 
Glutamatergic neurons expressing neurotensin in the posterior thalamus innervate 
the neurotensin-expressing GABAergic neurons in the central nucleus of the 
amygdala (Ma et al., 2019). Bidirectional optogenetic manipulation of the 
glutamatergic neurons in the posterior thalamus demonstrated their role in 
promoting sleep (Ma et al., 2019). Bidirectional optogenetic manipulation of the 
GABAergic central nucleus of the amygdala neurons demonstrated their role of 
broadly inhibiting multiple wake-promoting populations (Ma et al., 2019). 
REM sleep 
REM sleep is always preceded by NREM sleep and followed by 
wakefulness except in disorders like narcolepsy. REM sleep is accompanied by 
the unique phenomenon of muscle atonia, where muscle activity is abolished by 
silencing neuronal input.  
Neuronal populations that promote REM sleep are called REM-on while 
those that inhibit REM sleep are called REM-off. The main anatomical region for 
REM sleep control is the SLD, and REM-off regions include the vlPAG, the dorsal 
raphe, the PPT, and the DpMe (Peever & Fuller, 2017). Mutual inhibition between 
REM-on neurons and REM-off neurons has been investigated as the method 
controlling REM sleep state switching to prevent inappropriate shifts between 
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wakefulness and REM sleep, as seen with narcolepsy (Burgess & Scammell, 
2012; Chen et al., 2018; Lu et al., 2006).  
GABAergic neurons in the SLD project to many REM-off regions and are 
mutually inhibited by projections from those regions (Boissard et al., 2003; Hayashi 
et al., 2015; Kroeger et al., 2019; Liang et al., 2014; Lu et al., 2006; Sakai, 2018; 
Weber et al., 2018). Lesions of GABAergic neurons demonstrated their essential 
role for the inhibition of REM-off neuronal populations (Lu et al., 2006; Sapin et al., 
2009). Glutamatergic neurons in the SLD project to the vM and to the BF (Lu et 
al., 2006). Chemogenetic activation of glutamatergic SLD neurons demonstrated 
their prominent role in being able to drive all features of REM sleep (Erickson et 
al., 2019). Lesion and optogenetic inhibition of glutamatergic SLD neurons 
projecting to the medial septum demonstrated their critical role in generating REM 
sleep cortical activation and hippocampal theta rhythms (Boyce et al., 2016; Lu et 
al., 2006; Valencia Garcia et al., 2018).  
GABAergic neurons in the vM project to motor neurons in the spinal ventral 
horn (Chen et al., 2017; Lu et al., 2006; Valencia Garcia et al., 2018). Knockdown 
of neurotransmission of GABAergic vM neurons demonstrated their essential role 
in establishing REM sleep muscle atonia.  
As with wakefulness and NREM sleep, the hypothalamus is involved in 
REM sleep control. GABAergic and galaninergic neurons of the DMH project to the 
raphe pallidus (Chen et al., 2018). Optogenetic manipulation demonstrated their 
role in promoting REM sleep while suppressing NREM sleep (Chen et al., 2018). 
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Neurons in the LH expressing melanin-concentrating hormone (MCH) innervate 
the lateral pontine tegmentum (LPT) and the vlPAG (Kroeger et al., 2019). Dual 
optogenetic and chemogenetic manipulations of MCH neurons demonstrated their 
essential role in inhibiting the REM sleep suppression from vlPAG and LPT 
(Kroeger et al., 2019).  
Sleep-wake timing 
Many structured and cyclically rhythmic changes occur during the sleep-
wake cycle (Waterhouse et al., 2012). The coordination and timing of these 
changes create the framework for healthy sleep. A person’s circadian rhythm 
(process C) and homeostatic sleep pressure (process S) interact during the sleep-
wake cycle to determine sleep-wake timing (Borbély, 1982; Borbély et al., 2016).  
Circadian rhythm is an approximately 24-hour repeating cycle of changing 
genetic expression that impacts an organism from the molecular level to the 
behavioral level (Okamura et al., 2002; Reppert & Weaver, 2002). While cells 
contain this rhythm on their own, the suprachiasmatic nucleus (SCN) of the 
hypothalamus, known as the master clock, synchronizes the body (Shi et al., 
2019). The SCN signals the body, able to maintain synchronous circadian 
rhythmicity on its own, but light cycles can entrain it. The SCN follows the day-
night cycle by responding to light in the environment as detected by retinal ganglion 
cells (RGC), specialized neurons in the eye. RGCs detect and respond to blue 
light, signaling to the SCN directly (Brzezinski et al., 2005; Hattar et al., 2002). The 
SCN maintains coordinated oscillations even in the absence of lighting cycles 
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Process C represents the SCN signaling time of day information to the brain and 
body, synchronizing many physical, mental, and behavioral activities (Dibner et al., 
2010).  
Process S represents homeostatic sleep pressure, a drive to sleep that 
increases with more time spent awake and only decreases by sleeping (Friedman 
et al., 1979). Sleep pressure is thought to be produced in part by the build-up of 
small molecules such as adenosine and nitric oxide and requiring galanin signaling 
(Basheer et al., 2000; Dittrich et al., 2015; Dworak et al., 2017; Reichert et al., 
2019). Sleep pressure diminishes with time spent asleep and with the quality of 
sleep (Friedman et al., 1979).  
Process S and process C typically work in tandem as understood through 
the two-process model of sleep regulation (Borbély et al., 2016). In humans, during 
the day, process C provides progressively stronger activating signaling to remain 
awake even as process S increases during wakefulness. As part of the SCN 
continuing to maintain synchronized circadian rhythmicity, process C decreases 
and the built-up sleep pressure finally begins to reduce with the onset of sleep 
(Borbély et al., 2016). However, if the person does not go to sleep, process S 
continues to build instead (Borbély et al., 2016). The increased sleep pressure 
results in sleep rebound where excessive sleeping occurs in the next sleep 
episode to offset the previous sleep loss (Friedman et al., 1979). With continued 
sleep deprivation, sleep pressure can degrade the SCN’s synchrony since sleep 
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pressure is not controlled by the SCN (Dijk & Archer, 2010; Tobler et al., 1983; 
Wyatt et al., 1999).  
The interaction of circadian rhythm and homeostatic sleep pressure are 
important for overall sleep-wake timing (Daan et al., 1984). Sleeping at the time 
established by circadian rhythms increases quality of sleep (Zitting et al., 2018). 
When sleep quality is high, sleep pressure is more effectively removed (Friedman 
et al., 1979). These two processes individually signal to the neural circuitry that 
establishes sleep-wake control (Tobler et al., 1983). In this way, the interactions of 
process C and process S provide important structure to sleep timing (Daan et al., 
1984; Fang & Rao, 2017).  
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Figure 1.1: Wake-promoting Nuclei and Projections. 
Sagittal plane of a mouse brain showing that wake-promoting neurons are located 
in the brainstem and in the forebrain, and project to the cortex to actively promote 
cortical activation and wakefulness. Histaminergic neurons located in the TMN 
actively inhibit VLPO sleep-promoting neurons. Open circles, brain areas 
contributing to sleep control but not sleep-promoting per se. Dash line, functional 
connectivity to be confirmed; BF, basal forebrain; DR, dorsal raphe; LDT/PPT, 
laterodorsal and pedunculopontine tegmental nuclei; LH, lateral hypothalamus; 
LC, locus coeruleus; NAc, nucleus accumbens; NTS, nucleus of the solitary tract; 
PB, parabrachial nucleus; PZ, parafacial zone; RMTg, rostromedial tegmental 
nucleus; SLD, sublaterodorsal nucleus; TMN, tuberomamillary nucleus; vlPAG, 
ventrolateral periaqueductal gray; VLPO, ventrolateral preoptic area; VM, ventral 
medulla; VTA, ventral tegmental area; ZI, zona incerta. Modified from Gompf and 
Anaclet, 2020 with authorization.  
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Figure 1.2: NREM Sleep-promoting Nuclei and Projections. 
Sagittal plane of a mouse brain showing that NREM-promoting neurons are 
distributed along the neural axis and also in the cortex. They are mainly GABAergic 
and inhibit wake-promoting systems. Cortical interneurons and the thalamo-
cortico-thalamic feedback loop actively promote cortical synchronization. Open 
circles, brain areas contributing to sleep control but not sleep-promoting per se. 
BF, basal forebrain; DR, dorsal raphe; LDT/PPT, laterodorsal and 
pedunculopontine tegmental nuclei; LH, lateral hypothalamus; LC, locus 
coeruleus; Nac, nucleus accumbens; NTS, nucleus of the solitary tract; PB, 
parabrachial nucleus; PZ, parafacial zone; RMTg, rostromedial tegmental nucleus; 
SLD, sublaterodorsal nucleus; TMN, tuberomamillary nucleus; vlPAG, 
ventrolateral periaqueductal gray; VLPO, ventrolateral preoptic area; VM, ventral 
medulla; VTA, ventral tegmental area; ZI, zona incerta. Modified from Gompf and 
Anaclet, 2020 with authorization.  
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Figure 1.3: REM Sleep-promoting Nuclei and Projections. 
Sagittal plane of a mouse brain showing that REM sleep is driven by the SLD which 
projects rostrally to promote cortical activation and caudally to actively drive 
muscle atonia. SLD REM sleep-promoting neurons are glutamatergic and receive 
inhibitory inputs from the pontine wake-promoting neurons. The LH contributes to 
REM sleep by inhibiting the vlPAG REM-off neurons. Open circles, brain areas 
contributing to sleep control but not sleep-promoting per se. BF, basal forebrain; 
DR, dorsal raphe; LDT/PPT, laterodorsal and pedunculopontine tegmental nuclei; 
LH, lateral hypothalamus; LC, locus coeruleus; MN, motoneurons; Nac, nucleus 
accumbens; NTS, nucleus of the solitary tract; PB, parabrachial nucleus; PZ, 
parafacial zone; RMTg, rostromedial tegmental nucleus; SLD, sublaterodorsal 
nucleus; TMN, tuberomamillary nucleus; vlPAG, ventrolateral periaqueductal gray; 
VLPO, ventrolateral preoptic area; VM, ventral medulla; VTA, ventral tegmental 
area; ZI, zona incerta. Modified from Gompf and Anaclet, 2020 with authorization.  
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Project Summary 
Discovering sleep promoting neurons in the parafacial zone 
Investigating brain regions to discover the circuitry behind sleep-wake 
control is an ongoing endeavor. Even with the many sleep and wake brain regions 
that have been uncovered, their interaction and overall coordination require further 
study. While the wake-promoting reticular formation was revealed seventy years 
ago (Moruzzi & Magoun, 1949), the SWS-promoting regions have taken longer to 
find. Several SWS-promoting populations were located in the midbrain and even 
cortex, but less than a decade ago, a long sought-after population of neurons was 
finally located in the brainstem (Anaclet et al., 2012). These neurons are located 
in the parafacial zone (PZ), named for its location adjacent to the facial nerve, and 
are the subject of active scrutiny since there was very little pre-existing literature 
on the region. While the VLPO, the first identified SWS-promoting region, promotes 
SWS by inhibiting wake-promoting brain regions, the PZ exhibits the additional 
ability to increase SWA (Anaclet et al., 2014; Anaclet, Griffith, et al., 2018).  
The GABAergic neurons in the PZ (PZGABA) are essential for the onset and 
maintenance of SWS (Anaclet et al., 2014; Anaclet & Fuller, 2017; Anaclet et al., 
2012). Research indicates the PZGABA seems to be particularly powerful among 
the currently known SWS promoting systems since they promote SWA (Anaclet et 
al., 2014; Anaclet & Fuller, 2017). This has sparked a new abundance of study into 
this once poorly characterized region (Anaclet, et al., 2018; Erickson et al., 2019; 
Sakai, 2017; Venner et al., 2019). The boundaries of this sleep active neuronal 
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population remain undefined but are being investigated (Sakai, 2017). The 
parvocellular reticular nucleus part alpha exhibited no sleep-active neurons upon 
recording individual cell activity, thus establishing a boundary on the ventral side 
from the PZ (Sakai, 2017). The current understanding of the PZ is that it is a 
heterogeneous population of excitatory and inhibitory sleep active neurons 
(Anaclet et al., 2012; Erickson et al., 2019). Since PZGABA plays a critical part in 
sleep-wake control, and PZ sleep active neurons are not all GABAergic (Anaclet 
et al., 2012), we investigated the role of PZ non-GABAergic neurons in sleep-wake 
control.  
Characterizing PZ Neurons 
Previous research demonstrated that the GABAergic neurons in the PZ 
(PZGABA) are necessary for SWS (Anaclet et al., 2014; Anaclet et al., 2012). 
Inhibition of GABAergic transmission in PZGABA neurons resulted in insomnia, 
significantly reducing the amount of SWS compared to the control group (Anaclet 
et al., 2012). Utilizing the Designer Receptors Exclusively Activated by Designer 
Drugs system (DREADDs) demonstrated chemogenetic activation of PZGABA 
neurons is sufficient to induce SWS (Anaclet et al., 2014). Additionally, EEG 
measurements show that activation of PZGABA neurons by DREADDs produced a 
significant increase in SWS amount and SWA (Anaclet et al., 2014).  
Double immunohistochemistry labeling of both sleep active neurons and 
GABAergic neurons showed there were sleep active neurons not labeled as 
GABAergic (Anaclet et al., 2012). The Allen Mouse Brain Atlas from the Allen 
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Institute for Brain Science contains in situ hybridization data available at 
https://mouse.brain-map.org/experiment/show/73818754 indicating there are 
glutamatergic neurons in the PZ specifically expressing the vesicular-glutamate 
transporter 2 (Vglut2) gene (PZVglut2). Targeting Vglut2 expression in the PZVglut2 
neurons provided the ability to manipulate, label, and test glutamatergic neurons 
in the PZ for their possible involvement in sleep-wake control (Erickson et al., 
2019).  
DREADDs activation of PZVglut2 showed a significant increase in 
wakefulness (Erickson et al., 2019). However, the wake-promoting parabrachial 
nucleus is adjacent to the PZ and also contains Vglut2 expressing neurons. 
Imaging of DREADDs expression showed these wake-promoting neurons were 
possibly transfected, making it difficult to interpret if the recorded behavior was due 
to PZVglut2 neurons (Erickson et al., 2019). Therefore, to target PZVglut2 neurons 
more precisely, we used a specific marker of PZVglut2, the transcription factor called 
Paired Like Homeobox 2B (Phox2B). Labeling showed colocalization between 
PZVglut2 neurons and Phox2B-expressing neurons in the PZ [PZPhox2B; (Erickson et 
al., 2019)]. EEG recordings showed that activation of PZPhox2B neurons by the 
DREADDs system did not produce a significant change in the amount of sleep or 
wakefulness (Erickson et al., 2019). In conclusion, activation of PZPhox2B neurons 
is not sufficient to affect sleep-wake control (Erickson et al., 2019).  
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Despite this, it remained unclear if they were necessary. We then sought to 
determine if physiological sleep-wake behavior requires the connection and 
function of these neurons as documented in the following research.  
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Chapter 2  
 
Investigating the Role of Phox2B-expressing Glutamatergic Parafacial Zone 
Neurons in Sleep-Wake Control 
  
Abstract 
The parafacial zone (PZ) is a brain area that contains a heterogenous 
neuronal population currently under investigation for its role in sleep-wake control. 
PZ GABAergic neurons play an essential role in slow-wave-sleep, a characteristic 
of non-rapid eye movement sleep. Using the homeodomain transcription factor 
Phox2B as a specific marker for PZ glutamatergic neurons (PZPhox2B), 
chemogenetic activation of PZPhox2B-neurons was not sufficient to affect sleep-
wake phenotypes. However, it is not known if PZPhox2B neurons play a necessary 
role in sleep-wake control. We hypothesize that PZPhox2B neurons are required for 
normal sleep-wake phenotypes. We tested the hypothesis by injecting Phox2B-
IRES-Cre mice with an adeno-associated virus containing Cre-dependent 
diphtheria toxin subunit-A DNA to ablate PZPhox2B (PZPhox2B-DTA) neurons. Injection 
site mapping revealed transfection covering the PZ as well as the locus coeruleus 
(LC) which is known to express Phox2B. This research found that PZPhox2B-DTA mice 
did not have significantly altered amounts or quality of sleep-wake states. PZPhox2B-
DTA mice did have fragmented wakefulness during the active period but no changes 
in SWS or REM sleep, and no changes in any sleep-wake states during the rest 
period. Since targeted ablation of PZPhox2B-DTA neurons was not able to be 
confirmed, we cannot conclude that PZPhox2B neurons are necessary in sleep-wake 
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control. The limited sleep-wake phenotype could be due to partial lesion of Phox2B 
neurons or lesion in adjacent regions such as the LC.   
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Introduction 
It is widely understood that a restful night’s sleep is an important part of 
being healthy. Sleep amount and quality impacts a person’s physiology, 
psychology, and cognitive function (Grandner, 2017; Shi et al., 2018). Multiple 
neuronal populations have been discovered to be involved in wakefulness, slow 
wave sleep (SWS), and rapid eye movement (REM) sleep, as well as in the 
transitions between vigilance states. Recent discoveries revealing the complexity 
of interaction within and between the systems that establish dynamic regulation of 
sleeping and waking states are due to advances in more selective targeting and 
manipulation of specific neuronal populations (Gompf & Anaclet, 2020). Modern 
research makes use of powerful molecular and genetic tools available to 
investigate neurophysiological functions by targeted manipulation of defined 
neuronal subtypes within the targeted neuroanatomy of interest (Shiromani & 
Peever, 2017). However, our understanding of the neural networks and regulative 
processes behind sleeping and waking remains incomplete. 
Within the past decade, the medullary parafacial zone (PZ) has been 
identified and characterized as an essential and strong sleep promoting brain area 
(Anaclet et al., 2014; Anaclet, Griffith, et al., 2018; Anaclet et al., 2012). Located 
dorsal and lateral from the facial nerve, the boundaries of the PZ are still under 
investigation. Currently, the ventral border has begun to take shape by definitive 
exclusion of the parvicellular reticular nucleus part alpha (Sakai, 2017). It is also 
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known that the PZ contains sleep active neuronal populations of both GABAergic 
and non-GABAergic subtypes (Anaclet et al., 2012).  
The GABAergic neurons in the PZ have been found to be sufficient and 
necessary for SWS amount, consolidation, and sleep depth (Anaclet et al., 2014; 
Anaclet et al., 2012). Investigation into the sleep active non-GABAergic neurons in 
the PZ has begun by using the homeodomain transcription factor Phox2B 
(PZPhox2B) to target glutamatergic neurons (Erickson et al., 2019). Research sought 
to determine if PZPhox2B neurons were involved in sleep-wake control and acted 
synergistically with the PZGABA neurons. Chemogenetic activation of PZPhox2B 
neurons did not produce any alterations in sleep-wake amount, structure, or 
quality, suggesting they are not sufficient to affect the sleep-wake cycle. However, 
the necessity of PZPhox2B neurons remains to be determined.  
In this research, we hypothesized that PZPhox2B neurons are required for 
physiologically normal sleep and wakefulness. We tested this hypothesis by 
lesioning PZPhox2B neurons. We injected a cre-dependent AAV containing DTA into 
the PZ of Phox2B-IRES-cre mice (PZPhox2B-DTA). This research found that PZPhox2B-
DTA mice had fragmentation in waking during the active period but did not have 
significantly altered sleep-wake amount or quality during any time of day.   
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Materials and Methods 
Mice 
The study used twelve adult male Phox2B-IRES-cre [Jackson Laboratory 
#016223 (Rossi et al., 2011)] mice (8-12 weeks, 20-25 g) to target parafacial zone 
(PZ) neurons expressing Phox2B (PZPhox2B). Phox2B-IRES-Cre mice were 
crossed with a cre-dependent reporter mouse Flox-L10-GFP [Jackson Laboratory 
#24750 (Liu et al., 2014)] producing a Phox2B-GFP mouse line. Sixteen adult male 
Phox2B-GFP mice were used in attempts to label Phox2B. Genotyping was 
performed within the lab both before and after experiments. The mice were bred 
at the University of Massachusetts Medical School animal facility in a 12-hour 
light/dark cycle with lights on at 07:00 local time and lights off at 19:00 local time. 
The Institutional Animal Care and Use Committee of the University of 
Massachusetts Medical School approved all procedures (Protocol #A-2574).  
Surgery 
Naïve mice were intraperitoneally injected with ketamine/xylazine 
anesthetic (100 and 10 mg/kg, respectively). Once unresponsive to toe pinch, mice 
were subcutaneously injected with a preoperative nonsteroidal anti-inflammatory 
drug (Meloxicam, 5mg/kg) and securely placed in the Kopf stereotaxic apparatus 
(Germany). To selectively ablate PZPhox2B neurons, bilateral injections of an adeno-
associated virus (AAV; serotype 10) containing diphtheria toxin subunit-A (DTA) in 
a cre-dependent configuration [DTA-AAV, titer = 1.6x1013 viral genome copies per 
ml; Figure 2.1 on page 45; (Anaclet, et al., 2018; Kaur et al., 2017, Kaur et al., 
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2013)] was injected into the PZ [coordinates from Bregma: Antero-posterior = -5.6 
mm, Lateral = ± 1.0 mm, Dorso-ventral = 4.2 mm, as per The Mouse Brain in 
Stereotaxic Coordinates (Paxinos & Franklin, 2001)] of Phox2B-IRES-cre 
(PZPhox2B-DTA) experimental mice and littermate control mice not expressing Cre 
(PZPhox2B-WT). By placing the DNA sequence of DTA in an inverted fashion within a 
FLEX cassette, DTA cannot be transcribed except in the presence of cre-
recombinase, conferring absolute expression selectivity (Anaclet, et al., 2018; 
Kaur et al., 2017). With mCherry located on the construct but external to the FLEX 
switch, mCherry is expressed in all non-cre-recombinase cells within the injection 
field, thereby the anatomical extent of the injection to be ascertained and 
demonstrates quantitatively the “survival” of non-cre-recombinase cells 
intermingled with cre-recombinase cells targeted by DTA (Anaclet, et al., 2018; 
Kaur et al., 2017).  
For brain injection, the Neurostar Wireless Capillary Nanoinjector 
(Germany) was used to inject DTA-AAV (50 nl) with a borosilicated capillary pipette 
into the PZ bilaterally of mice. Dissolving surgical sutures were used to close the 
scalp wound and postoperative analgesic was administered subcutaneously 
(Buprenorphine, 0.05 mg/kg). Mice were kept in a clean, warm environment until 
resuming normal activity as previously described (Anaclet et al., 2015).  
After two weeks for recovery, mice were prepared for a second surgery with 
the same anesthetic, stereotaxic apparatus, and preoperative NSAID protocols. 
For EEG/EMG implantation surgery, mice were implanted with four EEG screw 
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electrodes  (Pinnacle Technology Inc., Catalog #8403) placed snugly in holes 
drilled into the skull with a Dremel 105 round engraving cutter bit (1/32 inch) in the 
frontal and parietal bones on each side, and two flexible EMG wire electrodes 
(Plastics One, catalog #E363/76/SPC) tucked under the trapezius muscle. 
Electrodes were previously soldered to a 6-pin connector (Heilind Electronics, 
catalog #853-43-006-10-001000). Dental cement was used to secure the 
assembly to the scalp. The mouse was given the same post-operative analgesic 
protocol and again placed in a clean, warm environment until resuming normal 
activity as previously described (Anaclet et al., 2015). Mice were individually 
housed after EEG/EMG implantation so the mice do not damage each other’s 
headsets. 
Sleep-wake monitoring 
One week after EEG/EMG implantation surgery, mice were relocated to 
transparent barrels placed in an insulated, sound-proofed recording chamber 
maintained at the ambient temperature of 22 ± 1°C and on a 12-hour light/dark 
cycle (lights on at 07:00 local time) with food and water available ad libitum. Mice 
were habituated to the recording cable for 5-7 days before the start of polygraphic 
recording. Vital Recorder (Kissei, Japan) was used to detect amplified (A-M 
System 3500, United States) and digitalized cortical EEG (ipsilateral frontoparietal 
leads) and EMG signals with a resolution of 256 Hz. Up to eight mice were 
simultaneously recorded for a 48-hour period with an equal number of PZPhox2B-WT 
and PZPhox2B-DTA mice.  
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Sleep scoring and analysis 
Polygraphic records were scored in 10 second epochs for wakefulness, 
slow wave sleep (SWS), and rapid eye movement (REM) sleep using SleepSign 
for Animal (Kissei, Japan) assisted by spectral analysis utilizing fast Fourier 
transform. Data from each group were analyzed as the percentages of time spent 
in wakefulness, SWS, and REM sleep hourly.   
To assess sleep-wake fragmentation, vigilance state bouts were separated 
into eight bout lengths [<30, 40-70, 80-150, 160-310, 320-630, 640-1270, 1280-
2550, and >2550 seconds; (Kantor et al., 2013; Mochizuki et al., 2004)]. For each 
vigilance state, a time-weighted frequency histogram was produced using the 
number of episodes and the percentage of each vigilance state occurring in each 
bout length and compared between PZPhox2B-DTA mice to PZPhox2B-WT mice.  
Sleep-wake power density was assessed by rescoring 3-hours of recording 
early in the rest period (10:00–13:00) and at the start of the active period (19:00-
22:00) into 4-second epochs of wakefulness, SWS, and REM sleep. Assessment 
included visually identifying epochs containing artifacts occurring during active 
wake (with large movements) or containing two vigilance states and omitting them 
from the spectral analysis. Mice were excluded from spectral analysis if more than 
20% of their 3-hour recording was omitted. Fast Fourier transform routine (FFT) 
was applied to the EEG to generate the power spectrum by computing consecutive 
4-second epochs within a frequency range of 0.5-120 Hz and 0.5 Hz bins. The 
data was normalized by expressing each frequency bin as a percentage of the 
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epoch total power. For analyzing the EEG frequency bands, the power bins were 
normalized as a percentage of total power then summed into delta (δ, 0.5 – 4 Hz), 
theta (θ, 4 – 9 Hz), alpha (α, 9 – 15 Hz),  beta (β, 15 – 30 Hz), low gamma (lγ, 30 
– 60 Hz), and high gamma (hγ, 60 – 120 Hz) bands. The difference was analyzed 
between each band for each sleep-wake state comparing PZPhox2B-DTA mice to 
PZPhox2B-WT mice for the 3-hours during the rest period (10:00-13:00) and for the 3-
hours during the active period (19:00-22:00).  
Prism v6 (Graphpad Software, San Diego, CA, United States) was used to 
perform statistical analyses. After confirming the data met the parameters for the 
ANOVA model, two-way repeated-measures ANOVA followed by a post hoc 
Bonferroni test were performed to determine significant differences in sleep-wake 
amount, fragmentation, and cortical EEG power density between PZPhox2b-DTA mice 
and PZPhox2B-WT mice. Welch’s t-test was performed to assess significant changes 
in 24-hour sleep-wake amount between PZPhox2b-DTA mice to PZPhox2B-WT mice.  
Injection site mapping 
At the end of the behavioral experiments, mice received ketamine/xylazine 
(200 and 20 mg/kg, respectively) intraperitoneal injections. Once the mice were 
deeply anesthetized and unresponsive to toe pinch, they were perfused 
transcardially with 20 ml of saline, followed by 100 ml of neutral phosphate-
buffered formalin (4%, Thermo Fisher Scientific). After extraction from the skull, 
brains were incubated in neutral phosphate-buffered formalin (4%, Thermo Fisher 
Scientific) for two hours, followed by 20% sucrose in 1x PBS until they sank.  
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Brains were sectioned at 40 µm into 3 series using a sliding, freezing 
microtome. To determine the region containing transfected cells, one series was 
mounted on slides, cover slipped using ProLong antifade Glass (Life Technologies 
#P36984) and viewed with a fluorescent microscope (Keyence BZ-X710, Japan). 
The boundary of the transfected area was mapped using mCherry native 
fluorescence expressed in all non-cre-recombinase expressing cells at the 
injection site, indicating the anatomic extent of transfection (Figure 2.2). 
Immunolabeling 
Since the homeodomain transcription factor Phox2B is expressed 
transiently during development in some neurons, GFP expression in Phox2B-GFP 
mice reflects developmental expression rather than adult expression of Phox2B-
cre (Kang et al., 2007; Pattyn et al., 1997). Therefore, GFP expression is not a 
reliable proxy for Phox2B-cre expressing neurons. To confirm the lesion of PZPhox2B 
neurons following DTA-AAV injection, we attempted immunolabeling of Phox2B.  
Series from sixteen Phox2B-GFP mice were immunostained for Phox2B 
using either monoclonal recombinant rabbit anti-Phox2B antibody (ab183741; 
Table 2.1 A) or polyclonal rabbit anti-Phox2B antibody (pa5-35044; Table 2.1 A) 
at varying concentrations (Table 2.2). Slices were then labeled with a secondary 
antibody conjugated to either a red fluorophore (CY1300, 1:1000; Table 2.1 B), or 
biotinylated (BA-1000, 1:1000; Table 2.1 B) and followed by either a far-red 
fluorophore (016-650-084, 1:1000; Table 2.1 C) or ABC (#PK-4000, Vectorlabs) 
followed by diaminobenzidine (DAB) reaction (Table 2.1 C).  
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Standard immunofluorescence and immunohistochemistry protocols were 
performed with parameters optimized during troubleshooting which included 
primary antibody concentration, antigen retrieval, and length of time incubating in 
the primary antibody [Table 2.2; (Venner et al., 2016)].  Antigen retrieval was 
attempted by incubating slices in 1x phosphate buffer saline (PBS, ph7.4) at 90°C 
in an oven for 10 minutes, or by incubating slices in Tris-EDTA buffer at 90°C in a 
water bath for 10 minutes. Primary antibodies were tested between a concentration 
of 1:5000 and 1:250 with incubation normally lasting two nights but some were 
extended to three nights. The parameters optimized are detailed in Table 2.2.  
To test if the absence of labeling was due to insufficient signal amplification, 
we use the DAB labeling technique which allow further amplification of the signal. 
This technique is appropriate for double labeling of cell cytoplasm and nucleus. In 
previous experiments, GFP has been shown to have a cytoplasmic localization 
while the transcription factor Phox2B has been shown to be nuclear (Liu et al., 
2014; Rossi et al., 2011). In Phox2B-GFP brain slices double-labeling using rabbit 
anti-Phox2B (Table 2.1 A) and chicken anti-GFP (Table 2.1 A), the appropriate 
biotinylated secondary antibody followed be Avidin/Biotin complex. GFP was 
labeled in brown and Phox2B in black using DAB staining. GFP expressing 
neurons are seen in brown (Figure 2.8) however, black labeling was not seen, in 
contrast to a previous report (Tiveron et al., 1996).  
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Figure 2.1: Viral construct for neuronal ablation 
Diagram depicting the AAV-Flex-DTA construct to express diphtheria toxin subunit 
A (DTA) in a cre-dependent configuration to genetically produce cell death in cre-
expressing neurons with mCherry to be expressed in transfected cre-negative 
cells. Abreviations: CMV, cytomegalovirus promoter; betaGl, beta glucosidase; 
hGHpA = the human growth hormone gene polyadenylation signal. Modified from 
Kaur et al., 2017 with authorization.  
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Figure 2.2: Transduced Neurons at the Injection Site for PZPhox2B-DTA mice 
Extent of transduced neurons with mCherry-positive somas is displayed for six 
individual Phox2B-IRES-cre mice that received bilateral injections of AAV-lox-
mCherry-lox-DTA-lox2 into the PZ (PZPhox2B-DTA). Boundaries of transduced 
neurons are mapped and represented on diagrams of mouse brain slices from The 
Mouse Brain in Stereotaxic Coordinates (Franklin & Paxinos, 2001) at anatomic 
locations Bregma -5.52 and -5.68 to display the PZ. Abreviations: 7n, seventh 
(facial) nerve; LC, locus coeruleus; PB, parabrachial nucleus; PZ, parafacial zone.   
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A) Primary Antibodies 
Antigen Host Source Catalog# Type 
Phox2B Rabbit  abcam  ab183741  Monoclonal, recombinant 
Phox2B Rabbit  Invitrogen  PA5-35044 Polyclonal 
GFP Chicken Invitrogen Ab262 - 
 
B) Secondary Antibodies 
Antigen Host Source Catalog# Labeling Marker Name 
Rabbit Goat Vector Labs BA-1000 Biotin 
Rabbit Goat Vector Labs CY-1300 Cy3  
Chicken Goat Vector Labs BA-90110 Biotin 
 
C) Labeling Method for Biotinilated Secondary Antibodies 
Antigen Host Source Catalog# Labeling Marker Name 
Biotin - Vector Labs PK-4000 ABC kit 
Biotin - Invitrogen 016-650-084 Alexa 790  
 
Table 2.1: Primary and Secondary Antibodies Used for Immunostaining 
Details for A) primary and B) secondary antibodies and C) the method used to 
visualize labeling of biotin secondary antibodies.  
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A) Rabbit anti-Phox2B (ab183741, abcam) 
# of 
mice 
Antibody 
Concentration 
Antigen 
Retrieval 
Incubation 
Length 
Labeling 
Marker 
Result 
  1  1:250 
 None 
 2 days 
 Cy3 No label 
  2  1:500 
  3  1:1000 
  2  1:5000 
  2  1:1000  DAB No label 
  2  1:500 
 Oven 
 90°C 
 Cy3 
No overlap with 
Phox2B-GFP   3  1:1000 
  1  1:500  Alexa 790 No label 
  1  1:250 
 3 days 
 Cy3 
No overlap with 
Phox2B-GFP 
  1  1:500 
  1  1:1000 
10  1:500  DAB High background, 
unclear if nuclear 
staining 
 
B) Rabbit anti-Phox2B (PA5-35044, Invitrogen) 
# of 
mice 
Antibody 
Concentration 
Antigen 
Retrieval 
Incubation 
Length 
Labeling 
Marker 
Result 
  1  1:1000  Water 
 Bath 
 100°C 
 2 days  Alexa 790 Tissue damaged 
  2  1:1000  DAB High background, 
unclear if nuclear 
staining 
 
Table 2.2: List of Parameters During Troubleshooting 
Combinations of optimized parameters for A) monoclonal Phox2B antibody and 
B) polyclonal Phox2B antibody labeling. Results are for best series outcome.  
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Results 
Transfection of Phox2B-cre neurons in the parafacial zone 
To test the necessity of PZPhox2B neurons in sleep-wake control, Phox2B-
IRES-Cre mice received bilateral injections into the PZ of DTA-AAV (Figure 2.1). 
The constitutive expression of mCherry encoded by the virus allowed us to see the 
anatomical extent of transduction at the injection site. Fluorescent visualization of 
the transduced neurons was used to map the transduction boundary. Six cre-
expressing mice used for behavioral state analysis displayed full coverage of 
mCherry labeling bilaterally in the PZ with some transduction in the parabrachial 
nucleus and locus coeruleus (Figure 2.2).   
PZPhox2B-DTA mice have unaltered sleep-wake amounts 
We analyzed sleep-wake phenotypes after bilateral injection of DTA-AAV 
into the PZ of Phox2B-IRES-cre mice. Cre-expressing mice (PZPhox2B-DTA) were 
compared with non-cre-expressing littermates (PZPhox2B-WT). We found that 
genotype did not affect the distribution of wakefulness (two-way ANOVA, 
F(23,207) = 1.03, p = 0.43; Figure 2.3 A1), SWS (two-way ANOVA, F(23,207) = 
1.059, p = 0.39; Figure 2.3 A2), or REM sleep (two-way ANOVA, F(23,207) = 0.74, 
p = 0.80; Figure 2.3 A3). To see if there may be a difference in overall amount of 
sleep-wake behavior during either the rest period (07:00-19:00) or the active period 
(19:00-07:00), we assessed the twelve hours of each period and the full 24 hours 
(07:00-07:00) of sleep-wake amount in PZPhox2B-DTA mice as compared with 
PZPhox2B-WT mice. There was no significant effect of the mouse genotype in the 
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amount of wakefulness (two-way ANOVA, F(1,9) = 1.84, p = 0.21; Figure 2.3 B1), 
SWS (two-way ANOVA, F(1,9) = 2.16, p = 0.18; Figure 2.3 B2), or REM sleep (two-
way ANOVA, F(1,9) = 0.41, p = 0.54; Figure 2.3 B3) for the rest and active period 
in PZPhox2B-DTA mice as compared to PZPhox2B-WT mice. There was also no significant 
difference in the 24 hour total amount for wakefulness (Welch’s t-test, p = 0.091; 
Figure 2.3 B1), SWS (Welch’s t-test, p = 0.108; Figure 2.3 B2), or REM sleep 
(Welch’s t-test, p = 0.166; Figure 2.3 B3) in PZPhox2B-DTA mice as compared to 
PZPhox2B-WT mice.  
PZPhox2B-DTA mice display increased wake fragmentation during the active 
period 
To determine if PZPhox2B-DTA mice have changes in sleep architecture, we 
evaluated the number of bouts and bout durations for each vigilance state. During 
the rest period, the mouse genotype did not have a significant effect on the number 
of wake bouts (two-way ANOVA, F(7,63) = 0.13, p = 0.99; Figure 2.4 A1), SWS 
bouts (two-way ANOVA, F(7,63) = 0.36, p = 0.92; Figure 2.4 A2), or REM sleep 
bouts (two-way ANOVA, F(7,63) = 0.73, p = 0.65; Figure 2.4 A3). Additionally, the 
percentage of wakefulness spent in each bout length (two-way ANOVA, F(7,63) = 
0.31, p = 0.95; Figure 2.4 B1), the percentage of SWS spent in each bout length 
(two-way ANOVA, F(7,63) = 0.04, p = 0.99; Figure 2.4 B2), and the percentage of 
REM sleep spent in each bout length (two-way ANOVA, F(7,63) = 0.79, p = 0.60; 
Figure 2.4 B3) was not affected by the mouse genotype.  
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During the active period, the number of bouts was significantly affected by 
the mouse genotype (two-way ANOVA, F(7,63) = 4.09, p = 0.0009; Figure 2.5 A1). 
PZPhox2B-DTA mice had a significant increase in the number of wakefulness bouts 
lasting 70 - 150 seconds (18.83 ± 2.6 vs 8.8 ± 1.7 in PZPhox2B-WT mice, p = 0.013; 
Figure 2.5 A1). This correlates with the significant effect of the mouse genotype on 
the proportion of wakefulness from various bout length (two-way ANOVA, F(7,63) 
= 3.12, p = 0.007; Figure 2.5 B1). PZPhox2B-DTA mice spent significantly less of their 
total wake time in bouts longer than 40 minutes (5.5 ± 4.2 vs 23.4 ± 6.4% in 
PZPhox2B-WT mice, p = 0.012; Figure 2.5 B1). While there was a trend towards 
increased proportion of wakefulness spent in the shorter bouts between 40 
seconds and 10 minutes. However, there was no effect of the mouse genotype in 
the number of SWS bouts (two-way ANOVA, F(7,63) = 0.93, p = 0.49; Figure 2.5 
A2) or in the percentage of total SWS time spent in each bout length (two-way 
ANOVA, F(7,63) = 0.97, p = 0.46; Figure 2.5 B2). Likewise, the mouse genotype 
did not affect the number of REM sleep bouts (two-way ANOVA, F(7,63) = 0.60, p 
= 0.759; Figure 2.5 A3) or the percentage of total REM sleep spent in each bout 
(two-way ANOVA, F(7,63) = 0.54, p = 0.80; Figure 2.5 B3).  
Cortical power distribution was not significantly affected in PZPhox2B-DTA mice  
To assess if PZPhox2B-DTA mice have altered cortical power distribution, 
vigilance states were analyzed for three hours during the rest period (10:00-13:00), 
and at the start of the active period (19:00-21:00). The mouse genotype did not 
significantly affect cortical EEG power distribution during wakefulness (two-way 
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ANOVA, F(5,24) = 0.23, p = 0.945; Figure 2.6 A1), SWS (two-way ANOVA, F(5,24) 
= 0.80, p = 0.559; Figure 2.6 A2), and REM sleep (two-way ANOVA, F(5,24) = 
0.44, p = 0.813; Figure 2.6 A3) during the rest period. Similarly, the mouse 
genotype did not significantly affect cortical EEG power distribution during 
wakefulness (two-way ANOVA, F(5,24) = 0.78, p = 0.572; Figure 2.6 B1), SWS 
(two-way ANOVA, F(5,24) = 0.13, p = 0.984; Figure 2.6 B2), or REM sleep (two-
way ANOVA, F(5,24) = 0.14, p = 0.983; Figure 2.6 B3) during the active period.  
Phox2B antibody immunostaining was unsuccessful 
To determine whether PZPhox2B neurons were successfully ablated by DTA-
AAV, we planned to utilize a rabbit anti-Phox2B antibody (Table 2.1 A) to label 
Phox2B-expressing neurons in adult mice. Initial labeling attempts were 
unsuccessful, and troubleshooting failed to produce a solution. Despite several 
methodological alterations (Table 2.2), we were not able to achieve successful 
labeling (Table 2.2; Figure 2.7, 2.8). In endogenously labeled Phox2B-GFP brain 
slices (Figure 2.7 A, D), immunolabeling of rabbit anti-Phox2B (Table 2.1 A) by the 
red fluorophore Cy3 (CY-13000; Table 2.1 B) did not successfully label Phox2B 
(Figure 2.7 C, F).  
Since GFP is located in the cytoplasm while the transcription factor Phox2B 
is localized to the nucleus, we used the DAB labeling technique to amplify the 
signal (Liu et al., 2014; Rossi et al., 2011). Phox2B-GFP brain slices were double-
labeled using rabbit anti-Phox2B (Table 2.1 A) and chicken anti-GFP (Table 2.1 
A), with the appropriate biotinylated secondary antibody followed by Avidin/Biotin 
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complex. GFP was labeled in brown using standard DAB staining, and Phox2B in 
black using DAB staining with Cobalt and Nickel. GFP expressing neurons are 
seen in brown (Figure 2.8) however, black labeling was not seen, in contrast to a 
previous report (Tiveron et al., 1996).   
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Figure 2.3: Sleep-wake Amounts 
(A) Hourly percentage of time (± S.E.M.) PZPhox2B-DTA mice spent in wakefulness 
(A1), slow-wave-sleep (A2), and REM sleep (A3) during a 24-hour period as 
compared with control (PZPhox2B-WT) mice. (B) The percentage of each sleep-wake 
state (±S.E.M.) in PZPhox2B-DTA mice as compared to PZPhox2B-WT mice during the 
rest period (07:00-19:00), the active period (19:00-07:00), and the entire 24-hour 
period (07:00-07:00). PZPhox2B-WT mice (n = 5) in black, PZPhox2B-DTA mice (n = 6) in 
color; no significant change, Welch’s t-test and two-way ANOVA for repeated-
measures (factor: hour). 
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Figure 2.4: Sleep Architecture During the Rest Period (07:00-19:00) 
(A) Number of episodes (±S.E.M.) spent in each bout length of wakefulness (W; 
A1), slow wave sleep (SWS; A2), and REM sleep (RS; A3) for PZPhox2B-DTA mice as 
compared to control (PZPhox2B-WT) mice during the rest period (07:00-19:00). (B) 
Time-weighted frequency histograms showing the portion (±S.E.M.) of 
wakefulness (B1), slow wave sleep (B2), or REM sleep (B3) amounts in each bout 
length as a percentage of the total amount of the vigilance stage in PZPhox2B-DTA 
mice as compared to PZPhox2B-WT mice during the rest period (07:00-19:00). 
PZPhox2B-WT mice (n=5) in black, PZPhox2B-DTA mice (n=6) in color; no significance, 
two-way ANOVA for repeated-measures (factor: bout length). 
  
56 
 
 
 
Figure 2.5: Sleep Architecture of the Active Period (19:00-07:00) 
(A) Number of episodes (±S.E.M.) spent in each bout length of wakefulness (W; 
A1), slow wave sleep (SWS; A2), and REM sleep (RS; A3) in PZPhox2B-DTA mice as 
compared to PZPhox2B-WT mice during the active period (19:00-07:00). (B) Time-
weighted frequency histograms showing the portion (±S.E.M.) of wakefulness (B1), 
slow wave sleep (B2), or REM sleep (B3) amounts in each bout length as a 
percentage of the total amount of the vigilance stage in PZPhox2B-DTA mice as 
compared to PZPhox2B-WT mice during the active period (19:00-07:00). PZPhox2B-WT 
mice (n=5) in black, PZPhox2B-DTA mice (n=6) in color; *p < 0.05, two-way ANOVA 
for repeated-measures (factor: bout length) followed by post hoc Bonferroni test. 
  
57 
 
 
 
Figure 2.6: Cortical EEG Power Distribution 
(A) The quantitative measures (±S.E.M.) of sleep-wake cortical EEG power in 
PZPhox2B-DTA mice as compared with PZPhox2B-WT mice for wakefulness (A1), slow 
wave sleep (A2), and REM sleep (A3) during 3 hours of the rest period (07:00-
19:00). (B) The quantitative measures (±S.E.M.) of sleep-wake cortical EEG power 
for wakefulness (B1), slow wave sleep (B2), and REM sleep (B3) during 3 hours 
of the active period (19:00-07:00) for PZPhox2B-DTA mice as compared with PZPhox2B-
WT mice. Power bands reported as delta (δ, 0.5-4 Hz), theta (θ, 4-9 Hz), alpha (α, 
9-15 Hz), beta (β, 15-30 Hz), low gamma (lγ, 30-60 Hz), and high gamma (hγ, 60-
120 Hz) frequency bands. Control mice (n=3) in black, DTA injected mice (n=3) in 
color; no significance, two-way ANOVA for repeated-measures (factor: power 
band). 
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Figure 2.7: Phox2B Immunofluorescence  
(A-C) Photomicrograph images of a Phox2B-GFP mouse brain showing GFP-
expressing neurons (A) in the PZ and LC, merged to show overlap (B) with 
attempted immunolabeling of Phox2B in red (Cy3; C). Scale bar: 300 µm. (D-F) 
Higher magnification of the box in (B). Photomicrograph images of Phox2B-
expressing GFP neurons (D) in the LC, merged to show overlap (E) with 
attempted immunolabeling of Phox2B in red (Cy3; F). Scale bar: 50 µm. 
Abbreviations: 7n, seventh (facial) nerve; LC, locus coeruleus; PZ, parafacial 
zone.   
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Figure 2.8: Phox2B Immunohistochemistry 
(A-B) Photomicrograph from a Phox2B-GFP mouse brain on different levels 
showing GFP DAB staining (cell bodies in brown) in the PZ and LC and 
attempted DAB immunolabeling of Phox2B which would be in black. Scale bar: 
100 µm. Abbreviations: 7n, seventh facial nerve; LC, locus coeruleus; PZ, 
parafacial zone.  
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Chapter 3  
 
Discussion 
 
PZPhox2B-DTA mice phenotype 
Previous research showed that GABAergic neurons in the PZ (PZGABA) are 
both sufficient and necessary for SWS (Anaclet et al., 2014; Anaclet et al., 2012). 
The PZ contains a heterogeneous population of neurons. Staining for c-fos, a 
neuronal marker for activity, found non-GABAergic sleep-active neurons in a 
region of the PZ containing glutamatergic neurons. Research investigating 
glutamatergic PZ neurons using Phox2B (PZPhox2B) as a marker found no 
significant sleep-wake effect when chemogenetically stimulated (Erickson et al., 
2019). That showed PZPhox2B neurons are not sufficient to affect sleep-wake 
phenotype, but it remained unclear if they were required for normal sleep-wake  
phenotypes.  
Based on this previous research (Erickson et al., 2019), we sought to 
determine the necessity of glutamatergic PZPhox2B neurons in sleep-wake control. 
The results here document the sleep-wake phenotype of mice after DTA-AAV 
injection into the PZ of Phox2B-IRES-cre (PZPhox2B-DTA) mice to ablate PZPhox2B 
neurons. Anatomical mapping confirmed coverage of the PZ by viral transfection 
using mCherry labeling (Figure 2.2). PZPhox2B-DTA mice had no significant difference 
in sleep-wake amount (Figure 2.3) nor in sleep-wake quality as measured by 
cortical power distribution (Figure 2.6) when compared to control mice (PZPhox2B-
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WT) for wakefulness, SWS, or REM sleep during the active and inactive periods. 
Additionally, PZPhox2B-DTA mice did not experience a change in sleep architecture 
as measured by proportion of the vigilance stage spent in different bout lengths 
during the rest period (Figure 2.4). There was not a change in sleep architecture 
for SWS and REM sleep during the active period either (Figure 2.5). PZPhox2B-DTA 
mice displayed a significant decrease in the amount of wakefulness spent in bouts 
longer than 40 minutes with a trend of increased amounts of wakefulness in bouts 
shorter than 10 minutes (Figure 2.5). This corresponds with the significant increase 
in the number of bouts that lasted 1 to 2.5 minutes and the trend of increased 
number of wakefulness bouts up to 10 minutes long in PZPhox2B-DTA mice as 
compared with PZPhox2B-WT mice. This suggests wake fragmentation during the 
active period; however, confirmation of the lesion was not possible.  
PZPhox2B neuronal lesion  
Phox2B-IRES-Cre mice have been shown to reliably mediate expression of 
cre-dependent factors (Rossi et al., 2011). DTA-AAV has been shown to reliably 
transfect and selectively ablate cre-expressing neurons (Anaclet, et al., 2018; Kaur 
et al., 2017). Therefore, transfected cre-expressing neurons at the PZ injection site 
were likely ablated. However, it needs to be confirmed both that only PZPhox2B 
neurons and all PZPhox2B neurons were ablated.  
The cre-dependent reporter mouse Flox-L10-GFP [Jackson Laboratory 
#24750 (Liu et al., 2014)] was crossed with the Phox2B-IRES-Cre mouse line, 
resulting in GFP labeling of Phox2B-expressing neurons (Phox2B-GFP). The GFP 
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expression is cre-dependent so it is persistent once turned on. As such, cells only 
need to express Phox2B once, at which time the Cre from the Phox2B locus 
facilitates recombination of GFP, resulting in persistent expression of GFP for the 
lifetime of the cell and in its progeny even if Phox2B is no longer being produced 
within the cell. For this reason, GFP expression in Phox2B-GFP mice may not 
accurately identify neurons expressing Phox2B in adulthood since Phox2B is a 
neurodevelopmentally important transcription factor.  As such, it was necessary to 
identify Phox2B in adult mice through a different method, such as immunolabeling. 
The Phox2B antibody previously published (Kang et al., 2007) did not result in 
specific labeling here for Phox2B-GFP mice (Figure 2.7, 2.8). Due to this, it cannot 
be said that the experimental results are due to lesion of PZPhox2B neurons, since 
lesion may be incomplete or may have occurred in nearby populations that also 
expressed Phox2B, such as the wake-promoting LC. 
Phox2B Relationship with Glutamatergic Neurons in the PZ 
The PHOX2B gene codes for a homeodomain transcription factor 
expressed exclusively in the nervous system. Prior research on Phox2B indicates 
that it plays a specific role in autonomic neuronal development and more 
specifically in neurons involved with breathing (Moreira et al., 2016). This 
transcription factor is essential for the differentiation of sympathetic neurons 
involved in the peripheral autonomic nervous system as Phox2B mutations are 
implicated in congenital central hypoventilation syndrome (Moreira et al., 2016).  
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Since this transcription factor is developmentally important, it may be 
expressed transiently in neurons that do not express it in adulthood. As such, a 
Phox2B-GFP mouse would display fluorescent labeling of all neurons that 
expressed the transcription factor at any time, even just during development, rather 
than only the neurons expressing it in adulthood. Therefore, in this study, Phox2B-
GFP mice were not used to identify Phox2B-expressing neurons in adult brains.    
Phox2B labeling in adult rats showed expression in the PZ (Kang et al., 
2007), although the physiological function of these PZ neurons had not been 
experimentally explored. These neurons became a new focus in sleep research 
with the revelation that some PZ neurons are more active during sleep as 
compared with wakefulness (Anaclet et al., 2012). Previous research found 
Phox2B highly colocalized with Vglut2 expression in the PZ but not in the nearby 
PB, making it an ideal marker for targeting PZVglut2 neurons while excluding the 
strongly wake-promoting PBVglut2 neurons (Erickson et al., 2019). However, 
Phox2B is a critical part of neurodevelopment for the neighboring LC and has been 
shown to be expressed in adulthood (Fan et al., 2018; Liu et al., 2020; Nobuta et 
al., 2015). Additionally, the LC contributes to wakefulness and when disrupted 
results in a decrease in wakefulness (Yamaguchi et al., 2018). This creates a need 
to confirm lesion specificity before the observed phenotype can be attributed to 
ablation of PZPhox2B neurons.  
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PZPhox2B neuron continuing investigation 
Since the ablation of PZPhox2B neurons remains unconfirmed, obtaining a 
reliable Phox2B antibody will be important for any further inquiries or conclusions 
with these neurons. The brains of PZPhox2B-DTA mice used in this research have 
been sectioned and stored for long-term preservation; confirmation of lesion could 
still be performed on these slices. Alternatively, a mouse line with Phox2B tagged 
by GFP directly (e.g. Phox2B-IRES-GFP) would make identification of adult 
expressing Phox2B neurons, and efficacy of ablation, much easier. 
Additionally, since the antibody for labeling Phox2B neurons did not reliably 
function, it remains to be confirmed whether these are the non-GABAergic sleep 
active neurons previously found (Anaclet et al., 2012). As previously published 
(Anaclet et al., 2012), brain sections from sleeping mice can be labeled with c-fos, 
a marker of neuronal activity, and double-labeled for Phox2B to look for 
colocalization. Comparing the anatomical mapping of these Phox2B sleep active 
neurons with mapping for Phox2B lesion will confirm that they occur in the same 
neuronal population. Phox2B-GFP mice labeled for c-fos may sufficiently 
demonstrate this.  
If neuronal ablation occurred within the LC, the wake fragmentation 
phenotype may be due to loss of those neurons (Yamaguchi et al., 2018) and not 
due to disrupting the functionality of PZPhox2B neurons. In this case, PZPhox2B 
neurons may not be involved in sleep-wake control and would no longer be of 
interest for a research group studying sleep. It remains to be considered, though, 
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that if the LC is affected, then the phenotype from the LC neurons and the 
phenotype from the PZPhox2B neurons may be masking each other. In this case, 
finding an even more specific neuronal marker for the glutamatergic PZ neurons 
of interest would be required. Single cell genomics of the PZ already underway 
may assist in doing so. If ablation of PZPhox2B neurons were complete and 
contained to only the PZ, then the reduction in wakefulness, while significant, does 
not prove these neurons are necessary for sleep-wake control since overall sleep 
and wake amounts were unaffected.  
Continuing to characterize PZ sleep-wake control 
While glutamatergic neurons are the only known non-GABAergic neuronal 
population in the PZ, it remains open for investigation if other types of sleep active 
neurons are present that are neither GABAergic nor glutamatergic. Future 
research can explore the in-situ hybridization data made available at the Allen 
Brain Atlas, although no candidates of interest were identified at this time. To 
confirm if there are additional sleep active neuronal population to identify, a 
VgatCre+ Phox2BCre+ tdTomato mouse could be generated and immunostained for 
c-fos, a marker of neuronal activity, in mice sacrificed during the rest period. If 
there is a substantial population of c-fos labeled neurons that are not labeled by 
the endogenously expressed Tomato, then the PZ brain region can be sorted to 
remove the fluorescent cells, providing a pure population for single cell genomic 
analysis to determine their neuronal subtype identity. The research contained here 
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provides a starting point for characterization of the PZ’s heterogeneous neuronal 
population.  
In making progress on better understanding the many recently identified 
sleep control regions, future endeavors would benefit the most by consolidating 
efforts on the PZGABA neurons. Efferent tracing has identified projections to the 
wake-promoting parabrachial nucleus (Anaclet et al., 2014), but it remains to be 
seen if there are additional targets. Afferent projections are also still unknown, 
leaving as a mystery the regions that inform and control the PZ for sleep activity.  
Potential interest for Phox2B  
Since research implicates Phox2B mutations in breathing control (Moreira 
et al., 2016; Nobuta et al., 2015), alteration in breathing may have occurred in 
PZPhox2B-DTA mice. No overt or dramatic phenotype was noticed; however, a lab 
with the resources and expertise for studying breathing in rodents would be best 
situated to conduct this investigation.   
Conclusion 
Using Phox2B as a specific neuronal marker facilitated investigation of PZ 
glutamatergic neurons’ role in sleep-wake control. Chemogenetic activation of 
PZPhox2B neurons demonstrated no evidence they are sufficient for sleep-wake 
control (Erickson et al., 2019). Cre-mediated ablation of PZPhox2B neurons, if 
confirmed, provide no evidence they are necessary for sleep-wake control. 
Altogether, our results provide no evidence that PZ glutamatergic neurons are 
essential for sleep-wake control and thus no evidence these neurons are of interest 
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for further investigations into sleep-wake control. Future lines of inquiry into sleep-
wake control in the PZ should focus on the GABAergic sleep-promoting neurons. 
This research combined with the previous study was important for establishing that 
glutamatergic PZ neurons do not contribute to sleep-wake control. Additionally, the 
documentation of these neurons provides new information about this previously 
uncharacterized region of the brain for future researchers to work with.     
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Appendix 1  
Erickson et al., 2019 
The following chapter is a manuscript published in the Frontiers of 
Neuroscience. Loris Ferrari performed in vitro experiments and provided the 
corresponding data for the figures and text. Heinrich Gompf performed RNAscope 
experiments and provided the corresponding images for the figures and data in the 
text. My contributions to this manuscript included analysis and manuscript 
preparation of all other data in Figures 1 through 5, 7, and 8. Christelle Anaclet 
planned and performed all other experiments and prepared all other elements of 
the manuscript.  
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